S. Gail Eckhardt

Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer

Ghassan K. Abou‐Alfa, Richard Létourneau, Graydon Harker et al. · Journal of Clinical Oncology · 2006 · 277 citations · Full text

Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

John A. Flygare, Maureen H. Beresini, Nageshwar Budha et al. · Journal of Medicinal Chemistry · 2012 · 247 citations · Full text

Apoptosis, Cell Death, Clinical Candidate +20

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Christopher H. Lieu, Erica A. Golemis, Ilya G. Serebriiskii et al. · Clinical Cancer Research · 2019 · 236 citations

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Robert H. Vonderheide, Janice P. Dutcher, Jeanne E. Anderson et al. · Journal of Clinical Oncology · 2001 · 224 citations

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

David Rinaldi, John G. Kuhn, Howard A. Burris et al. · Cancer Chemotherapy and Pharmacology · 1999 · 174 citations

Medicinal Chemistry, Pharmaceutical Science, Preclinical Drug Evaluation +10